These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 13441673

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of drugs in psychodynamic investigations.
    CATTELL JP.
    Proc Annu Meet Am Psychopathol Assoc; ; ():218-35. PubMed ID: 13441672
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical and physiological study of mescaline sulfate- and lysergic acid-induced reactions in mental disorders].
    LARICCHIA R, SANGUINETI I, ZAPPAROLI GC.
    Riv Sper Freniatr Med Leg Alien Ment; 1956 Oct 01; 80(4):887-918. PubMed ID: 13390719
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of mescaline and D-lysergic acid in psychiatric treatment.
    Malitz S.
    Dis Nerv Syst; 1966 Jul 01; 7 Suppl(7):39-42. PubMed ID: 5965283
    [No Abstract] [Full Text] [Related]

  • 7. A new adjunct to the treatment of alcoholism: the hallucinogenic drugs.
    SMITH CM.
    Q J Stud Alcohol; 1958 Sep 01; 19(3):406-17. PubMed ID: 13579169
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Prospective psychiatry; the time factor].
    JOST F, PEMSL H.
    Munch Med Wochenschr; 1957 Jun 14; 99(24):889-91. PubMed ID: 13451569
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Mescaline and psychotherapy].
    Turns D, Denber HC.
    Arzneimittelforschung; 1966 Feb 14; 16(2):251-3. PubMed ID: 6013809
    [No Abstract] [Full Text] [Related]

  • 14. Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication; effects of premedication with BOL-128 (2-bromo-d-lysergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine.
    CLARK LD, BLISS EL.
    AMA Arch Neurol Psychiatry; 1957 Dec 14; 78(6):653-5. PubMed ID: 13478222
    [No Abstract] [Full Text] [Related]

  • 15. Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio).
    Meldrum BS, Naquet R.
    Electroencephalogr Clin Neurophysiol; 1971 Dec 14; 31(6):563-72. PubMed ID: 4111479
    [No Abstract] [Full Text] [Related]

  • 16. Lysergide in the treatment of neurosis. (A report of two cases).
    Denson R.
    Dis Nerv Syst; 1966 Aug 14; 27(8):511-4. PubMed ID: 5329972
    [No Abstract] [Full Text] [Related]

  • 17. "Ritalin" and "sodium amytal": an alternative to L.S.D. 25 as an adjunct to psychotherapy.
    Martin I.
    Med J Aust; 1966 Dec 31; 2(27):1264-7. PubMed ID: 5957602
    [No Abstract] [Full Text] [Related]

  • 18. Steroids and moods: correlations in schizophrenics and subjects treated with lysergic acid diethylamide (LSD), mescaline, tetrahydrocannabinol, and synhexyl.
    Hollister LE.
    J Clin Pharmacol J New Drugs; 1969 Dec 31; 9(1):24-9. PubMed ID: 5250309
    [No Abstract] [Full Text] [Related]

  • 19. Some general observations on the usefulness of lysergic acid in psychiatry.
    Livingstone D.
    N Z Med J; 1966 Oct 31; 65(410):657-65. PubMed ID: 4224461
    [No Abstract] [Full Text] [Related]

  • 20. Clinical reactions of schizophrenics to sodium amytal, pervitin hydrochloride, mescaline sulfate, and d-lysergic acid diethylamide (LSD25).
    PENNES HH.
    J Nerv Ment Dis; 1954 Feb 31; 119(2):95-112. PubMed ID: 13163687
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.